Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

New clinical data shows Naviscan's PEM Flex scanner benefits for breast cancer management

Naviscan PET Systems : 14 December, 2007  (New Product)
Naviscan PET Systems has announced new clinical data from a study using the PEM Flex scanner in breast cancer management.
The new data was presented at the San Antonio Breast Cancer Symposium in the USA.

PEM Flex Solo II is a commercially available, FDA cleared high resolution PET scanner designed to image small body parts such as the breast and hand. Solo II utilises PET technology for the breast application known as positron emission mammography or PEM, which allows physicians to visualise and characterise lesions as small as two millimetres in size.

Kathy Schilling, MD and medical director of Breast Imaging and Intervention at the Center for Breast Care at the Boca Raton Community Hospital in Florida presented data from its study involving 90 breast cancer patients, comparing the effectiveness and accuracy of breast imaging with PEM, MRI and WB PET/CT for pre-operative surgical planning.

'PEM's high resolution imaging is right in the range of ductal size which is where cancer typically originates. We were pleased to find PEM demonstrated 93 percent sensitivity with ductal carcinoma in-situ cases and PEM also proved to be as sensitive as MRI in detecting invasive and non-invasive primary breast lesions,' said Dr Schilling who has been studying PEM for over a year. 'Besides the image quality of PEM and its ability to light up very small lesions, there is an ease of interpretation as you are only looking at some 48 images as opposed to hundreds with MRI.'

Dr Schilling has been using the PEM Flex scanner in her practice as a tool for evaluating additional and unsuspected disease in the breast and compares these findings with that of MRI. She is also a principal investigator in a 400 patient, multi-centre clinical trial comparing PEM and MRI in breast cancer patients to be completed in 2008.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo